Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-10-04 Sale |
2024-10-04 7:15 pm |
Travere Therapeutics Inc. | TVTX | LYONS GARY A Director |
40,000 | $14.73 | $589,101 | 51,000 (Direct) |
View |
2024-08-13 Sale |
2024-08-15 5:21 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
11,570 | $150.43 | $1,740,450 | 119,047 (Direct) |
View |
2024-07-16 Sale |
2024-07-18 4:54 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
930 | $150.03 | $139,530 | 130,617 (Direct) |
View |
2024-05-14 Sale |
2024-05-16 4:55 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
12,500 | $135.63 | $1,695,370 | 129,447 (Direct) |
View |
2023-12-22 Sale |
2023-12-27 4:10 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
10,000 | $130.04 | $1,300,443 | 193,697 (Direct) |
View |
2023-12-01 Sale |
2023-12-05 4:54 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
5,000 | $116.77 | $583,837 | 203,697 (Direct) |
View |
2023-09-12 Sale |
2023-09-14 4:51 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
5,000 | $115.02 | $575,120 | 208,697 (Direct) |
View |
2023-09-01 Sale |
2023-09-06 4:25 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
5,000 | $110.06 | $550,316 | 213,697 (Direct) |
View |
2022-10-31 Sale |
2022-11-02 6:42 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
15,000 | $114.76 | $1,721,403 | 203,697 (Direct) |
View |
2022-10-04 Sale |
2022-10-05 7:00 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
5,000 | $110.54 | $552,711 | 203,697 (Direct) |
View |
2022-04-25 Sale |
2022-04-27 5:26 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
15,000 | $92.76 | $1,391,393 | 208,697 (Direct) |
View |
2021-10-07 Sale |
2021-10-12 6:34 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
5,000 | $105.06 | $525,294 | 208,697 (Direct) |
View |
2021-06-10 Sale |
2021-06-14 8:25 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
10,000 | $100.27 | $1,002,743 | 213,697 (Direct) |
View |
2021-01-25 Sale |
2021-01-27 9:53 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
2,000 | $120.02 | $240,047 | 223,697 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-10-04 Exercise |
2024-10-04 7:15 pm |
N/A 2024-10-08 |
Travere Therapeutics Inc. | TVTX | LYONS GARY A Director |
40,000 | $0 | 51,000 (Direct) |
View |
2024-10-04 Exercise |
2024-10-04 7:15 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | LYONS GARY A Director |
40,000 | $10.48 | 51,000 (Direct) |
View |
2024-08-13 Exercise |
2024-08-15 5:21 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
11,570 | $42.76 | 119,047 (Direct) |
View |
2024-08-13 Exercise |
2024-08-15 5:21 pm |
N/A 2025-05-28 |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
11,570 | $0 | 119,047 (Direct) |
View |
2024-07-16 Exercise |
2024-07-18 4:54 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
930 | $42.76 | 130,617 (Direct) |
View |
2024-07-16 Exercise |
2024-07-18 4:54 pm |
N/A 2025-05-28 |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
930 | $0 | 130,617 (Direct) |
View |
2024-05-22 Option Award |
2024-05-23 6:17 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
4,417 | $0 | 4,417 (Direct) |
View |
2024-05-17 Exercise |
2024-05-21 4:57 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
2,100 | $0 | 119,047 (Direct) |
View |
2024-05-14 Exercise |
2024-05-16 4:55 pm |
N/A 2025-05-28 |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
12,500 | $42.76 | 129,447 (Direct) |
View |
2024-05-08 Option Award |
2024-05-10 4:05 pm |
2025-05-08 2034-05-07 |
Travere Therapeutics Inc. | TVTX | LYONS GARY A Director |
26,000 | $0 | 70,500 (Direct) |
View |
2023-12-01 Exercise |
2023-12-05 4:54 pm |
N/A 2024-05-22 |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
5,000 | $12.98 | 203,697 (Direct) |
View |
2023-09-12 Exercise |
2023-09-14 4:51 pm |
N/A 2024-05-22 |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
5,000 | $12.98 | 208,697 (Direct) |
View |
2023-09-01 Exercise |
2023-09-06 4:25 pm |
N/A 2024-05-22 |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
5,000 | $12.98 | 213,697 (Direct) |
View |
2023-05-26 Option Award |
2023-07-12 6:45 pm |
N/A 2033-05-26 |
RIGEL PHARMACEUTICALS INC | RIGL | LYONS GARY A Director |
55,000 | $0 | 105,000 (Direct) |
View |
2023-05-17 Option Award |
2023-05-19 5:15 pm |
N/A 2033-05-17 |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
6,390 | $0 | 6,390 (Direct) |
View |
2023-05-17 Option Award |
2023-05-19 4:05 pm |
2024-05-17 2033-05-16 |
Travere Therapeutics Inc. | TVTX | LYONS GARY A Director |
18,000 | $0 | 58,000 (Direct) |
View |
2023-05-01 Option Award |
2023-05-02 6:44 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | LYONS GARY A Director |
150,437 | $0 | 150,437 (Direct) |
View |
2023-02-01 Option Award |
2023-02-02 6:07 pm |
N/A 2033-02-01 |
Eledon Pharmaceuticals Inc. | ELDN | LYONS GARY A Director |
20,000 | $0 | 20,000 (Direct) |
View |
2022-10-31 Exercise |
2022-11-02 6:42 pm |
N/A 2023-05-23 |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
15,000 | $12.71 | 203,697 (Direct) |
View |
2022-05-20 Option Award |
2022-05-23 5:50 pm |
N/A 2032-05-20 |
RIGEL PHARMACEUTICALS INC | RIGL | LYONS GARY A Director |
55,000 | $0 | 80,000 (Direct) |
View |
2022-05-18 Option Award |
2022-05-20 4:02 pm |
N/A 2032-05-18 |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
9,724 | $0 | 9,724 (Direct) |
View |
2022-05-17 Option Award |
2022-05-17 5:15 pm |
2023-05-17 2032-05-17 |
Brickell Biotech Inc. | BBI | LYONS GARY A Director |
65,000 | $0 | 65,000 (Direct) |
View |
2022-05-11 Option Award |
2022-05-12 8:24 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | LYONS GARY A Director |
12,000 | $0 | 49,000 (Direct) |
View |
2022-04-25 Exercise |
2022-04-27 5:26 pm |
N/A 2022-05-23 |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
15,000 | $6.66 | 208,697 (Direct) |
View |
2022-02-01 Option Award |
2022-02-02 5:33 pm |
N/A 2032-02-01 |
Eledon Pharmaceuticals Inc. | ELDN | LYONS GARY A Director |
20,000 | $0 | 20,000 (Direct) |
View |
2021-06-14 Option Award |
2021-06-14 4:43 pm |
2022-06-14 2031-06-14 |
Brickell Biotech Inc. | BBI | LYONS GARY A Director |
40,000 | $0 | 40,000 (Direct) |
View |
2021-05-19 Option Award |
2021-05-21 8:50 pm |
N/A 2031-05-19 |
RIGEL PHARMACEUTICALS INC | RIGL | LYONS GARY A Director |
55,000 | $0 | 55,000 (Direct) |
View |
2021-05-19 Option Award |
2021-05-20 4:03 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
8,833 | $0 | 8,833 (Direct) |
View |
2021-05-14 Option Award |
2021-05-18 9:22 pm |
2022-05-14 2031-05-13 |
Travere Therapeutics Inc. | TVTX | LYONS GARY A Director |
12,000 | $0 | 46,000 (Direct) |
View |
2020-12-31 Tax Withholding |
2021-01-05 6:32 pm |
N/A N/A |
Brickell Biotech Inc. | BBI | LYONS GARY A Director |
5,967 | $0.78 | 18,762 (Direct) |
View |
2020-09-15 Option Award |
2020-09-17 5:06 pm |
N/A N/A |
Brickell Biotech Inc. | BBI | LYONS GARY A Director |
11,934 | $0.81 | 84,729 (Direct) |
View |
2020-09-15 Option Award |
2020-09-17 5:06 pm |
N/A 2030-09-15 |
Brickell Biotech Inc. | BBI | LYONS GARY A Director |
60,000 | $0 | 84,729 (Direct) |
View |
2020-09-11 Option Award |
2020-09-15 8:18 pm |
N/A 2030-09-11 |
Novus Therapeutics Inc. | NVUS | LYONS GARY A Director |
1,167 | $0 | 1,167 (Direct) |
View |
2020-08-31 Exercise |
2020-09-02 4:22 pm |
N/A N/A |
Brickell Biotech Inc. | BBI | LYONS GARY A Director |
692 | $0 | 12,795 (Direct) |
View |
2020-08-31 Tax Withholding |
2020-09-02 4:22 pm |
N/A N/A |
Brickell Biotech Inc. | BBI | LYONS GARY A Director |
8,977 | $0.94 | 12,795 (Direct) |
View |
2020-07-31 Tax Withholding |
2020-08-04 5:09 pm |
N/A N/A |
Brickell Biotech Inc. | BBI | LYONS GARY A Director |
346 | $0.92 | 21,772 (Direct) |
View |
2020-07-31 Exercise |
2020-08-04 5:09 pm |
N/A N/A |
Brickell Biotech Inc. | BBI | LYONS GARY A Director |
692 | $0 | 21,772 (Direct) |
View |
2020-06-30 Exercise |
2020-07-02 2:01 pm |
N/A N/A |
Brickell Biotech Inc. | BBI | LYONS GARY A Director |
691 | $0 | 22,118 (Direct) |
View |
2020-06-30 Tax Withholding |
2020-07-02 2:01 pm |
N/A N/A |
Brickell Biotech Inc. | BBI | LYONS GARY A Director |
346 | $1 | 22,118 (Direct) |
View |
2020-05-19 Option Award |
2020-05-21 6:52 pm |
2020-06-19 2030-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
6,018 | $0 | 6,018 (Direct) |
View |
2020-05-15 Option Award |
2020-05-19 8:00 pm |
2021-05-15 2030-05-14 |
Retrophin Inc. | RTRX | LYONS GARY A Director |
12,000 | $0 | 43,000 (Direct) |
View |
2020-05-15 Option Award |
2020-05-15 8:50 pm |
N/A 2030-05-15 |
RIGEL PHARMACEUTICALS INC | RIGL | LYONS GARY A Director |
55,000 | $0 | 55,000 (Direct) |
View |